Page 9 - Nasdaq Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Prudential PLC cut its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 37.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,770 shares of the biopharmaceutical company’s stock after selling 2,831 shares during the quarter. Prudential PLC’s holdings in Regeneron Pharmaceuticals […]

Phoenix Holdings Ltd. lowered its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 53.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 638 shares of the biopharmaceutical company’s stock after selling 739 shares during the period. Phoenix […]

Approval based on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth approved indication for...

QRG Capital Management Inc. purchased a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 20,148 shares of the biopharmaceutical company’s stock, valued at approximately $16,581,000. Several other large investors have also recently added to or reduced […]

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) saw a large growth in short interest in January. As of January 31st, there was short interest totalling 1,250,000 shares, a growth of 16.8% from the January 15th total of 1,070,000 shares. Based on an average daily volume of 576,700 shares, the short-interest ratio is currently 2.2 […]